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Abstract: Silver nanoparticles (AgNPs) have been shown to exhibit strong antibacterial 
activity against both Gram-positive bacteria and Gram-negative bacteria including antibiotic 
resistant strains. The antibacterial activity of AgNPs against Escherichia coli and 
Streptococcus mutans (S. Mutans) has been reported and found to be size dependent.  This 
study aims to compare the bactericidal effect of different shaped AgNPs (spherical and 
truncated octahedral) against E.coli and E.faecium. The antimicrobial activity of a range of 
concentrations (50, 100, 1000µg/ml) was determined over 24 hours using both optical density 
and viable counts. Truncated octahedral AgNPs (AgNoct) were found to be more active when 
compared with spherical AgNPs (AgNS).  The difference in shape resulted in  differences in 
efficacy which may be due to the higher surface area of AgNOct compared to AgNS, and 
differences in active facets and surface energies, with AgNPs having a bacteriostatic effect 
and AgNOct is being bactericidal after 4 hours. The results suggest that AgNPs can be used 
as effective growth inhibitors in different microorganisms, rendering them applicable to 
various medical devices and antimicrobial control systems. 
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1-Introduction 
Increasing numbers of microbial organisms are becoming resistant to antibiotics 
demonstrating a need for new, effective antibacterial agents [1].  In this regard, nanoscale 
materials have emerged as potential candidates in this area due to their unique physical and 
chemical properties [2]. The antibacterial effects of silver (Ag) salt are well known, and  
have been utilised to control bacterial growth in various devices and applications; these 
include catheters, dentistry, burn wounds, coated medical devices and water filtration [3] 
[4].  Moreover, a potential benefit of the use of nanoscale Ag particles (AgNPs) against 
microorganisms, e.g. Escherichia coli and Enterococcus faecium [5], is that such organisms 
are unlikely to build up resistance against AgNPs due to their broad spectrum of activity, 
unlike the narrow-targets of conventional antibiotics [6]. This activity includes the ability to 
attach through electrostatic interaction to the cell membrane and penetrate inside the 
bacteria, where they interact with sulphur-containing proteins and phosphorus containing 
compounds such as DNA [7]. Also, they have been shown to act upon the respiratory chain 
and replication of the bacterial cells leading to cell death [8].  
 
The antibacterial activity of AgNps against E.coli and Streptococcus mutans has been 
investigated previously and found to be size dependent, demonstrating that AgNPs of 5nm 
exhibit higher antibacterial activity when compared to 15nm and 55nm particles in Gram-
positive and Gram-negative bacteria [9]. The antimicrobial efficacy of NPs can also depend 
on their shape. Pal et al. (2007) showed truncated triangular AgNPs exhibit E.coli inhibition 
at 1 μg; however, in order for spherical NPs to inhibit E.coli 12.5 μg was required, with rod 
NPs needing a total of 50 to 100 μg of silver content [7]. In our previous work, copper 
nanocubes showed enhanced antibacterial activity on E.coli and E.faecium compared with 
copper nanospheres [10].  This study aims to determine shape dependence (spherical and 
truncated octahedral) on the antimicrobial efficacy of AgNP against E.coli and E.faecium. 
 
  2-Experiment 
2.1-Materials 
All chemicals for this work were purchased from Sigma-Aldrich, UK, without further 
purification. They include silver nitride (AgNO3), sodium bromide (NaBr), 
polyvinylpyrrolidone (PVP) ([C6H9NO]n), ethylene glycol (EG) (C2H6O2) and sodium 
citrate (C6H5Na3). 
2.2-Synthesis of AgNOct 
To synthesise AgNPOct, 3ml of two EG solutions, one containing 144mM PVP and 
0.11mM NaBr, the other containing 94mM AgNO3, were added dropwise via a two-channel 
syringe pump to 5ml of EG heated in a condenser at 160 °C. A 30µL drop of 10mM NaBr 
was then added to the pre-heated EG. The reaction solution turned yellow in a few seconds 
after the addition of AgNO3 and PVP demonstrating the formation of AgNPs. After 10 
minutes, the yellow colour faded in intensity due to oxidative etching and remained a light 
yellow colour for approximately 10 minutes before turning to brown and then to grey as the 
NPs increased in size. The synthesised  NPs were then centrifuged at 4600rpm three times 
and washed with de-ionised water ((DI) 18.2M MilliQ)  to remove any impurities and 
unreacted precursors. The reactions governing the particles formation are expressed as 
follows [11]: 
   2HO      OH→ 2   CHO + 2  O 
2    + 2   CHO→    CO-CO    + 2Ag +2 
  
These reactions usually occur in the presence of a mediating species such as sodium 
bromide, sodium sulphide, sodium borohydride and hydrochloric acid. These mediators 
(NaBr in this case), play a role in the etching of the particle seeds, facilitating the formation 
of truncated octahedrons. The PVP also works as a shape-control agent prompting the 
reduction of AgN   onto specific crystal faces while preventing reduction onto others. 
  2.3- Synthesis of AgNS 
To synthesize spherical AgNPs, an aqueous solution of AgNO3 0.001M was heated to 100°C 
and then 3ml of sodium citrate was added. The mixture continued to be heated until the 
colour changed to yellow. To remove contamination and unreacted precursors from the 
AgNSs, a combination of centrifugation and DI water washes was used three times as before. 
The particles were produced by reducing AgNO3 through the following reaction [12]:  
 
4Ag
+
 + C6H5O7Na3 + 2H2O → 4Ag
0
 + C6H5O7H3 + 3Na
+
 + H
+ 
+ O2↑ 
2.4-Particle characterisation 
The AgNPs of both shapes were characterised using ultraviolet/visible (UV-VIS) 
spectroscopy (Evolution 300 UV-VIS, over the wavelength range 300nm to 700nm), 
scanning electron microscopy (SEM) and energy-dispersive X-ray (EDX) spectroscopy 
(LEO S430), and X-ray diffraction (XRD) Bruker D8 Advance diffractometer). The various 
solutions were drop-cast onto silicon and glass substrates for SEM/EDX and UV-VIS/XDR 
investigations respectively. 
 
2.5-Antibacterial activity studies 
All investigation were carried out in triplicate on at least two separate occasions 
2.5.1-Bacterial strains and culture conditions 
The antibacterial activities of the AgNPs were investigated using E.coli (NCTC8196) and 
E.faecium (NCTC12202) as models for Gram-negative bacteria and Gram-positive bacteria 
respectively. Bacteria strains were stored in Luria Bertani broth at -80°C; bacteria were then 
cultured in nutrient broth (NB) at 37 °C for 24 hours. 
2.5.2- Screening of AgNPs for antibacterial activity 
A disc diffusion method was used to determine the antibacterial activity of both shapes of 
AgNPs. In brief, overnight cultures of E.coli and E. faecium were spread-plated on to 
nutrient agar (NA), a 2cm paper disc was then impregnated with 50µl of 100µg/ml of both 
shapes of AgNPs and placed on the surface of the NA and incubated at 37°C for 24 hours.  
Zones of inhibition were then measured.   
2.5.3-Determinig the growth curve of E. coli and E. faecium bacteria cells exposed to 
different concentration of AgNPs using optical density 
 
To investigate the growth kinetics curves of bacterial cells exposed to AgNPs different   
concentrations of both shapes (1000 µg, 100 µg and 50 µg) were used.  Aliquots of 200µl of 
either E.coli or E. faecium in the presence of AgNPs were dispensed into 96-well plates. 
Optical densities (OD) were measured every hour (from 0 to 24 hour) at 600nm using a 
spectrophotometer (Spectra Max Plus 384). The control was wells containing bacteria only.  
  2.5.4-Viable count growth curves 
An overnight culture of either E. coli or E. faecium, was inoculated into fresh NB (10
8
) 
containing either AgNOct or AgNS of 1000µg/ml. The cultures were then incubated at 37 
°C in a shaking incubator and samples taken at 0, 2, 4, 6 and 24 h. Aliquots of 100µl were 
spread-plated on to NA and incubated at 37 °C for 24h. Plates were then enumerated. 
 
  3-Results and discussion 
 
The absorption spectrum of the AgNOct solution in Figure 1a shows an intense peak at 
485nm with shoulders at 345nm and 365nm. The shape and position of plasmon absorption 
of AgNPs are mainly dependent on dielectric medium, particle size and the surface 
adsorbed species [5]. Anisotropic particles such as truncated octahedrons could have two or 
more SPR bands depending on the shape of the particles. However, only a single SPR band 
is present in the absorption spectra of spherical NPs. Figure 1b shows a sharp and intense 
peak at 410nm that is attributable to the surface plasmon absorption of spherical AgNPs 
[13]. 
SEM images of prepared AgNOct and AgNS are shown in Figure 2 (a and b respectively). 
The AgNOct have an average diameter of ∼194nm. The size distribution is calculated from 
SEM images, where the polydispersity is 25% (Figure 3a). Figure 2b shows spherically-
shaped NPs having an average diameter of ∼195nm, where the polydispersity is 26% 
(Figure 3b). EDX analysis of the AgNPs shows the high purity of both sets of samples 
(Figure4 a and b). 
 
XRD data shown in Figure 5 (a and b) confirms the formation of FCC AgNPs. Diffraction 
peaks at 2θ are 38, 44, 64, 77, 81, which are attributed to (111), (200), (202), (311) and 
(222) lattice planes of Ag with a cubic phase (JCPDS card no. 04-0783.  AgNOct have 
higher intensities of (200), (202), (311) and (222) lattice planes compared with AgNS. 
Generally, spherical AgNPs exhibit a dominant (100) peak, while truncated octahedron 
AgNPs exhibit (111) with a lower intensity of (100). It has been reported previously that the 
reactivity of Ag is enhanced by high atomic density facets such as (111) [5][14]. It was 
postulated that atoms were more reactive on the facets of higher surface energy, which may 
lead them to interact rapidly with oxygen-containing groups of lipopolysaccharide 
molecules that can result in enhanced attachment to the cell membrane [14]. 
Screening data shows that both shapes of AgNPs inhibit the growth of E.coli and E. faecium 
(the zone of inhibition was 2cm for both bacteria), as inhibition only occurred where there 
was direct contact with the AgNPs. The efficacy of spherical and truncated octahedral 
AgNPs was elucidated against E.coli and E. faecium using optical density. E.coli treated 
with AgNOct showed completely inhibited growth for all concentrations (1000, 100, 50µg) 
(Figure 6). However, there was limited growth in E. faecium at lower concentrations (50, 
100 µg), with only 1000 µg completely inhibiting (Figure 7). Consequently the inhibitory 
effects were higher in E.coli compared with E. faecium for AgNOct. 
Inhibition of E.coli treated with AgNS occurred at 10 hours with 1000µg/ml (Figure 8). For 
E. faecium, inhibition occurred in the first 6 hours at the same concentration and then 
limited growth began to occur (Figure 9). When viable count growth curves were generated 
in the presence of 1000µg/ml for both AgNOct and AgNS, the use of AgNOct against both 
bacteria resulted in the organisms being killed after 4 hours, demonstrating a bactericidal 
effect. Whereas, in the presence of AgNS there was only a modest reduction in CFU/mls in 
both organisms, demonstrating a bacteriostatic effect (Figure 10 and Figure 11). The viable 
count growth curves for untreated E.coli and E. faecium are shown in Figure 12 as a control. 
The surface area of AgNOct was 1.32  /g, while for AgNS it was 1.26  /g. The data in 
Table 1 suggests that the shape effect on the antibacterial activity of AgNPs may be 
attributed to the higher surface areas and facet reactivity; AgNPs with larger effective 
contact areas and higher reactive facets exhibit stronger antibacterial activity [15]. 
Moreover, the antibacterial activity of AgNOct may be related to their geometric structure 
where AgNOcts exhibit higher intensities than AgNSs of (200), (202), (311) and (222) 
lattice planes that might result in an increase in antibacterial activity. 
The greater inhibitory effects observed in E.coli than in E. faecium are attributed to 
differences in the structure and thickness of the peptidoglycan layer of their cell walls. The 
peptidoglycan layer of Gram-positive bacteria such as E. faecium (∼20-80nm) is thicker 
than that in Gram-negative bacteria such as E. coli (∼7-8nm), as it includes linear  
polysaccharide chains cross-linked by short peptides to make a three dimensional rigid 
structure.  This makes it more difficult for NPs to attach and penetrate [16]. In addition, the 
positively charged AgNPs are attracted electrostatically to the negatively charged 
lipopolysaccharides and teichoic acids in Gram negative and Gram-positive bacteria 
respectively; this may lead to rupture and protein denaturation followed by cell death [17].  
4-Conclusion 
During this study AgNOct and AgNS were synthesised by a chemical reduction method in 
EG and DI water respectively. The NPs were characterised using UV-VIS, SEM, EDX and 
XRD. The antimicrobial efficacy of the AgNPs has been shown to be shape dependent 
against the organisms tested. AgNOcts demonstrate bactericidal activity compared with 
bacteriostatic behaviour of AgNS. It is suggested that the bactericidal effect of AgNOct may 
be due to their geometric structure, higher surface area and higher surface energies when 
compared to AgNSs. This higher reactivity may ultimately lead to cell death more rapidly. 
Work in ongoing to determine more fully the mechanisms of action of the AgNPs that lead 
to the demonstrated bactericidal effects. 
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Time Control 
E.coli 
Control 
E.faecium 
E.coli 
treated 
with AgNS 
E.coli 
treated 
with 
AgNOct 
Enterococcus   
treated with 
AgNS 
Enterococcus   
treated with 
AgNoct 
0 hours 115×    120×    115 ×        
±21 
115 ×      
±21 
120 ×     ±20 120 ×     ±20 
2 hours 160×    165×    120 ×       
±21 
100 ×      
±11 
130 ×      ±11 115 ×     ± 23 
4 hours 180×    185×    115 ×       
±17 
No growth 125×       ±19 No growth   
6 hours 200×     210×    110 ×       
±14 
No growth 125 ×      ±15 No growth 
24 hours 180×    180×    100 ×       
±24 
No growth 120×       ±12 No growth 
 
Table1 :  Viable count growth curves in the prescence of  AgNOct and AgNS for E.coli and  
E.faecium  
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1-Introduction 
Increasing numbers of microbial organisms are becoming resistant to antibiotics 
demonstrating a need for new, effective antibacterial agents [1].  In this regard, nanoscale 
materials have emerged as potential candidates in this area due to their unique physical and 
chemical properties [2]. The antibacterial effects of silver (Ag) salt are well known, and  
have been utilised to control bacterial growth in various devices and applications; these 
include catheters, dentistry, burn wounds, coated medical devices and water filtration [3] 
[4].  Moreover, a potential benefit of the use of nanoscale Ag particles (AgNPs) against 
microorganisms, e.g. Escherichia coli and Enterococcus faecium [5], is that such organisms 
are unlikely to build up resistance against AgNPs due to their broad spectrum of activity, 
unlike the narrow-targets of conventional antibiotics [6]. This activity includes the ability to 
attach through electrostatic interaction to the cell membrane and penetrate inside the 
bacteria, where they interact with sulphur-containing proteins and phosphorus containing 
compounds such as DNA [7]. Also, they have been shown to act upon the respiratory chain 
and replication of the bacterial cells leading to cell death [8].  
 
The antibacterial activity of AgNps against E.coli and Streptococcus mutans has been 
investigated previously and found to be size dependent, demonstrating that AgNPs of 5nm 
exhibit higher antibacterial activity when compared to 15nm and 55nm particles in Gram-
positive and Gram-negative bacteria [9]. The antimicrobial efficacy of NPs can also depend 
on their shape. Pal et al. (2007) showed truncated triangular AgNPs exhibit E.coli inhibition 
at 1 μg; however, in order for spherical NPs to inhibit E.coli 12.5 μg was required, with rod 
NPs needing a total of 50 to 100 μg of silver content [7]. In our previous work, copper 
nanocubes showed enhanced antibacterial activity on E.coli and E.faecium compared with 
copper nanospheres [10].  This study aims to determine shape dependence (spherical and 
truncated octahedral) on the antimicrobial efficacy of AgNP against E.coli and E.faecium. 
 
  2-Experiment 
2.1-Materials 
All chemicals for this work were purchased from Sigma-Aldrich, UK, without further 
purification. They include silver nitride (AgNO3), sodium bromide (NaBr), 
polyvinylpyrrolidone (PVP) ([C6H9NO]n), ethylene glycol (EG) (C2H6O2) and sodium 
citrate (C6H5Na3). 
2.2-Synthesis of AgNOct 
To synthesise AgNPOct, 3ml of two EG solutions, one containing 144mM PVP and 
0.11mM NaBr, the other containing 94mM AgNO3, were added dropwise via a two-channel 
syringe pump to 5ml of EG heated in a condenser at 160 °C. A 30µL drop of 10mM NaBr 
was then added to the pre-heated EG. The reaction solution turned yellow in a few seconds 
after the addition of AgNO3 and PVP demonstrating the formation of AgNPs. After 10 
minutes, the yellow colour faded in intensity due to oxidative etching and remained a light 
yellow colour for approximately 10 minutes before turning to brown and then to grey as the 
NPs increased in size. The synthesised  NPs were then centrifuged at 4600rpm three times 
and washed with de-ionised water ((DI) 18.2M MilliQ)  to remove any impurities and 
unreacted precursors. The reactions governing the particles formation are expressed as 
follows [11]: 
   2HO      OH→ 2   CHO + 2  O 
2    + 2   CHO→    CO-CO    + 2Ag +2 
  
These reactions usually occur in the presence of a mediating species such as sodium 
bromide, sodium sulphide, sodium borohydride and hydrochloric acid. These mediators 
(NaBr in this case), play a role in the etching of the particle seeds, facilitating the formation 
of truncated octahedrons. The PVP also works as a shape-control agent prompting the 
reduction of AgN   onto specific crystal faces while preventing reduction onto others. 
  2.3- Synthesis of AgNS 
To synthesize spherical AgNPs, an aqueous solution of AgNO3 0.001M was heated to 100°C 
and then 3ml of sodium citrate was added. The mixture continued to be heated until the 
colour changed to yellow. To remove contamination and unreacted precursors from the 
AgNSs, a combination of centrifugation and DI water washes was used three times as before. 
The particles were produced by reducing AgNO3 through the following reaction [12]:  
 
4Ag
+
 + C6H5O7Na3 + 2H2O → 4Ag
0
 + C6H5O7H3 + 3Na
+
 + H
+ 
+ O2↑ 
2.4-Particle characterisation 
The AgNPs of both shapes were characterised using ultraviolet/visible (UV-VIS) 
spectroscopy (Evolution 300 UV-VIS, over the wavelength range 300nm to 700nm), 
scanning electron microscopy (SEM) and energy-dispersive X-ray (EDX) spectroscopy 
(LEO S430), and X-ray diffraction (XRD) Bruker D8 Advance diffractometer). The various 
solutions were drop-cast onto silicon and glass substrates for SEM/EDX and UV-VIS/XDR 
investigations respectively. 
 
2.5-Antibacterial activity studies 
All investigation were carried out in triplicate on at least two separate occasions 
2.5.1-Bacterial strains and culture conditions 
The antibacterial activities of the AgNPs were investigated using E.coli (NCTC8196) and 
E.faecium (NCTC12202) as models for Gram-negative bacteria and Gram-positive bacteria 
respectively. Bacteria strains were stored in Luria Bertani broth at -80°C; bacteria were then 
cultured in nutrient broth (NB) at 37 °C for 24 hours. 
2.5.2- Screening of AgNPs for antibacterial activity 
A disc diffusion method was used to determine the antibacterial activity of both shapes of 
AgNPs. In brief, overnight cultures of E.coli and E. faecium were spread-plated on to 
nutrient agar (NA), a 2cm paper disc was then impregnated with 50µl of 100µg/ml of both 
shapes of AgNPs and placed on the surface of the NA and incubated at 37°C for 24 hours.  
Zones of inhibition were then measured.   
2.5.3-Determinig the growth curve of E. coli and E. faecium bacteria cells exposed to 
different concentration of AgNPs using optical density 
 
To investigate the growth kinetics curves of bacterial cells exposed to AgNPs different   
concentrations of both shapes (1000 µg, 100 µg and 50 µg) were used.  Aliquots of 200µl of 
either E.coli or E. faecium in the presence of AgNPs were dispensed into 96-well plates. 
Optical densities (OD) were measured every hour (from 0 to 24 hour) at 600nm using a 
spectrophotometer (Spectra Max Plus 384). The control was wells containing bacteria only.  
  2.5.4-Viable count growth curves 
An overnight culture of either E. coli or E. faecium, was inoculated into fresh NB (10
8
) 
containing either AgNOct or AgNS of 1000µg/ml. The cultures were then incubated at 37 
°C in a shaking incubator and samples taken at 0, 2, 4, 6 and 24 h. Aliquots of 100µl were 
spread-plated on to NA and incubated at 37 °C for 24h. Plates were then enumerated. 
 
  3-Results and discussion 
 
The absorption spectrum of the AgNOct solution in Figure 1a shows an intense peak at 
485nm with shoulders at 345nm and 365nm. The shape and position of plasmon absorption 
of AgNPs are mainly dependent on dielectric medium, particle size and the surface 
adsorbed species [5]. Anisotropic particles such as truncated octahedrons could have two or 
more SPR bands depending on the shape of the particles. However, only a single SPR band 
is present in the absorption spectra of spherical NPs. Figure 1b shows a sharp and intense 
peak at 410nm that is attributable to the surface plasmon absorption of spherical AgNPs 
[13]. 
SEM images of prepared AgNOct and AgNS are shown in Figure 2 (a and b respectively). 
The AgNOct have an average diameter of ∼194nm. The size distribution is calculated from 
SEM images, where the polydispersity is 25% (Figure 3a). Figure 2b shows spherically-
shaped NPs having an average diameter of ∼195nm, where the polydispersity is 26% 
(Figure 3b). EDX analysis of the AgNPs shows the high purity of both sets of samples 
(Figure4 a and b). 
 
XRD data shown in Figure 5 (a and b) confirms the formation of FCC AgNPs. Diffraction 
peaks at 2θ are 38, 44, 64, 77, 81, which are attributed to (111), (200), (202), (311) and 
(222) lattice planes of Ag with a cubic phase (JCPDS card no. 04-0783.  AgNOct have 
higher intensities of (200), (202), (311) and (222) lattice planes compared with AgNS. 
Generally, spherical AgNPs exhibit a dominant (100) peak, while truncated octahedron 
AgNPs exhibit (111) with a lower intensity of (100). It has been reported previously that the 
reactivity of Ag is enhanced by high atomic density facets such as (111) [5][14]. It was 
postulated that atoms were more reactive on the facets of higher surface energy, which may 
lead them to interact rapidly with oxygen-containing groups of lipopolysaccharide 
molecules that can result in enhanced attachment to the cell membrane [14]. 
Screening data shows that both shapes of AgNPs inhibit the growth of E.coli and E. faecium 
(the zone of inhibition was 2cm for both bacteria), as inhibition only occurred where there 
was direct contact with the AgNPs. The efficacy of spherical and truncated octahedral 
AgNPs was elucidated against E.coli and E. faecium using optical density. E.coli treated 
with AgNOct showed completely inhibited growth for all concentrations (1000, 100, 50µg) 
(Figure 6). However, there was limited growth in E. faecium at lower concentrations (50, 
100 µg), with only 1000 µg completely inhibiting (Figure 7). Consequently the inhibitory 
effects were higher in E.coli compared with E. faecium for AgNOct. 
Inhibition of E.coli treated with AgNS occurred at 10 hours with 1000µg/ml (Figure 8). For 
E. faecium, inhibition occurred in the first 6 hours at the same concentration and then 
limited growth began to occur (Figure 9). When viable count growth curves were generated 
in the presence of 1000µg/ml for both AgNOct and AgNS, the use of AgNOct against both 
bacteria resulted in the organisms being killed after 4 hours, demonstrating a bactericidal 
effect. Whereas, in the presence of AgNS there was only a modest reduction in CFU/mls in 
both organisms, demonstrating a bacteriostatic effect (Figure 10 and Figure 11). The viable 
count growth curves for untreated E.coli and E. faecium are shown in Figure 12 as a control. 
The surface area of AgNOct was 1.32  /g, while for AgNS it was 1.26  /g. The data in 
Table 1 suggests that the shape effect on the antibacterial activity of AgNPs may be 
attributed to the higher surface areas and facet reactivity; AgNPs with larger effective 
contact areas and higher reactive facets exhibit stronger antibacterial activity [15]. 
Moreover, the antibacterial activity of AgNOct may be related to their geometric structure 
where AgNOcts exhibit higher intensities than AgNSs of (200), (202), (311) and (222) 
lattice planes that might result in an increase in antibacterial activity. 
The greater inhibitory effects observed in E.coli than in E. faecium are attributed to 
differences in the structure and thickness of the peptidoglycan layer of their cell walls. The 
peptidoglycan layer of Gram-positive bacteria such as E. faecium (∼20-80nm) is thicker 
than that in Gram-negative bacteria such as E. coli (∼7-8nm), as it includes linear  
polysaccharide chains cross-linked by short peptides to make a three dimensional rigid 
structure.  This makes it more difficult for NPs to attach and penetrate [16]. In addition, the 
positively charged AgNPs are attracted electrostatically to the negatively charged 
lipopolysaccharides and teichoic acids in Gram negative and Gram-positive bacteria 
respectively; this may lead to rupture and protein denaturation followed by cell death [17].  
4-Conclusion 
During this study AgNOct and AgNS were synthesised by a chemical reduction method in 
EG and DI water respectively. The NPs were characterised using UV-VIS, SEM, EDX and 
XRD. The antimicrobial efficacy of the AgNPs has been shown to be shape dependent 
against the organisms tested. AgNOcts demonstrate bactericidal activity compared with 
bacteriostatic behaviour of AgNS. It is suggested that the bactericidal effect of AgNOct may 
be due to their geometric structure, higher surface area and higher surface energies when 
compared to AgNSs. This higher reactivity may ultimately lead to cell death more rapidly. 
Work in ongoing to determine more fully the mechanisms of action of the AgNPs that lead 
to the demonstrated bactericidal effects. 
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